AKT1 and urinary bladder carcinoma: Our study demonstrated that treatment of RT4 and T24 bladder cancer cells with sorafenib or CR-BAY 5:1 reduced Akt and Erk phosphorylation, which may be closely related to the decrease in proliferation and induction of apoptosis we observed.